AARTIPHARM price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- AARTIPHARM
- MB Code
- MBEQU4711
- ISIN
- INE0LRU01027
- BSE code
- 543748
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 582.64 Cr
- Net profit
- 61.12 Cr
- EPS
- 6.74
- YoY revenue
- +3.35%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for AARTIPHARM
Dividend of ₹1.50 per share
Ex-date corporate action
Dividend of ₹2.50 per share
Ex-date corporate action
Aarti Pharmalabs shares rose 1.37% to Rs 882 following the inauguration of phase 1 of its new greenfield manufacturing facility in Atali,…
Aarti Drugs reported a 63% YoY increase in Q1 net profit, with margins improving to 12.6%, indicating strong financial performance.
Aarti Pharmalabs Ltd. share price updates, performance news, and stock details for this public company incorporated on 22/11/2019.
Price returns
Historical performance
Technicals
Indicator consensus